I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Currently, acute aortic dissection (AAD) remains the most common catastrophic aortic condition.\[[@ref1]\] AAD requires rapid diagnosis and appropriate treatment to improve survival and prevent potentially fatal complications.\[[@ref2][@ref3]\] Over the past two decades, understanding on the natural history, diagnosis, and management of AAD has improved considerably. Although several studies have focused on AAD, few data exist on sex-related differences in clinical presentation, diagnostic imaging, management, and outcomes in a large cohort.\[[@ref4][@ref5]\] Accordingly, the purpose of this investigation was to evaluate differences between male and female patients with AAD and to report both early and late outcomes over a 15-year period in our center.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

The study was approved by the Ethics Committee of the General Hospital of the Shenyang Military Region.

Study population and data collection {#sec2-2}
------------------------------------

We examined data on all patients with AAD admitted to the General Hospital of the Shenyang Military Region from June 2002 to May 2016 (*n* = 884). Multidetector computed tomography was performed in all cases.\[[@ref6]\] Acute type A dissection was defined as any dissection that involved the ascending aorta and/or aortic arch. Acute type B was defined as that involving the descending aorta (without any tear in or involvement of the ascending aorta) appearing within 14 days of the onset of symptoms.\[[@ref7][@ref8][@ref9]\] Patients were divided into two groups according to sex.

Management and follow-up protocol {#sec2-3}
---------------------------------

While uncomplicated type B dissection can usually be managed with conservative treatment, type A dissection is a surgical emergency.\[[@ref10]\] With improving technology and convincing long-term outcomes in favor of thoracic endovascular aortic repair (TEVAR), there is growing consensus for TEVAR to be used for both complicated and uncomplicated Type B aortic dissection.\[[@ref8][@ref11]\] After discharge, antihypertensive medicine was administered. For those requiring intervention, new deficits, not present before the operation, were considered postoperative outcomes. All cases were followed up clinically at 1, 6, 12 months, and annually thereafter.

Endpoints {#sec2-4}
---------

The study\'s primary endpoint during the follow-up was the composite of aortic disease-related death, aortic dissection, paraplegia, myocardial ischemia, renal insufficiency, and other aortic complications.

Statistical analysis {#sec2-5}
--------------------

Summary statistics of both groups (male and female) were presented as frequencies and percentages, median (Q~1~ and Q~3~), or mean ± standard deviation (SD). For categorical variables, significant differences between groups were assessed with the Chi-square test or Fisher\'s exact test, and continuous parameters were assessed with Student\'s *t*-test. Pre- and intra-operative variables were first analyzed using univariate analysis to determine whether any single factor was related to mortality in all patients. Many individual variables were examined using multivariate analysis by forward logistic regression to estimate the independent odds ratios (*OR*s) of factors related to mortality in patients. Univariate and stratified survival statistics were computed using Kaplan-Meier analysis. Subjects who did not return to the clinic and those we were unable to contact were considered as lost to follow-up. Data analysis was performed using Statistical Package for Social Sciences (SPSS) version 20.0 for Windows (SPSS Institute, Chicago, IL, USA). A value of *P* \< 0.05 was considered statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Sex-related differences in demographics, clinical characteristics, and imaging findings {#sec2-6}
---------------------------------------------------------------------------------------

A total of 884 patients (76.1% male, mean age 51.4 ± 11.8 years) were included in this study. Baseline characteristics by sex are presented in [Table 1](#T1){ref-type="table"}. There were fewer current smokers in female compared with male (17.5% vs. 67.2%, *χ*^2^ = 160.06, *P* \< 0.05). The percentage of men who reported regular alcohol consumption was significantly higher than that in women (40.6% vs. 3.8%, *χ*^2^ = 100.18, *P* \< 0.05). There were no significant differences in hypertension (79.8% vs. 77.3%, *χ*^2^ = 0.69, *P* = 0.41), diabetes mellitus (3.9% vs. 5.7%, *χ*^2^ = 1.30, *P* = 0.25), coronary heart disease (19.5% vs. 21.3%, *χ*^2^ = 0.35, *P* = 0.56), or type of dissection (38.3% vs. 46.0%, *χ*^2^ = 3.90, *P* = 0.05) between men and women. Proportions with classic presentation with chest pain (82.2% vs. 78.7%, *χ*^2^ = 1.29, *P* = 0.26), abdominal pain (16.0% vs. 10.9%, *χ*^2^ = 3.37, *P* = 0.07), and back pain (57.7% vs. 64.9%, *χ*^2^ = 3.53, *P* = 0.06) were similar. Combined pericardial effusion was seen in 16.6% of men and 22.3% of women, with a trend (*χ*^2^ = 3.46, *P* = 0.06) toward higher incidence in women. The mean systolic and diastolic blood pressure did not differ between the groups \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographics and history of acute aortic dissection patients

  Characteristics                       Men (*n* = 673)   Women (*n* = 211)   Statistical values   *P*
  ------------------------------------- ----------------- ------------------- -------------------- --------
  Age (years), mean ± SD                51.4 ± 11.8       55.1 ± 12.5         2.71^†^              0.10
  Smoking, *n* (%)                      452 (67.2)        37 (17.5)           160.06\*             \<0.05
  Drinking, *n* (%)                     273 (40.6)        8 (3.8)             100.18\*             \<0.05
  Hypertension, *n* (%)                 537 (79.8)        163 (77.3)          0.69\*               0.41
  Coronary heart disease, *n* (%)       131 (19.5)        45 (21.3)           0.35\*               0.56
  Diabetes mellitus, *n* (%)            26 (3.9)          12 (5.7)            1.30\*               0.25
  Type A dissection, *n* (%)            258 (38.3)        97 (46.0)           3.90\*               0.05
  Chest pain, *n* (%)                   553 (82.2)        166 (78.7)          1.29\*               0.26
  Back pain, *n* (%)                    388 (57.7)        137 (64.9)          3.53\*               0.06
  Abdominal pain, *n* (%)               108 (16.0)        23 (10.9)           3.37\*               0.07
  Limb ischemia, *n* (%)                47 (7.0)          7 (3.3)             3.76\*               0.05
  Coma/alter consciousness, *n* (%)     50 (7.4)          23 (10.9)           2.56\*               0.11
  Congestive heart failure, *n* (%)     19 (2.8)          7 (3.3)             0.14\*               0.71
  Pleural effusion, *n* (%)             171 (25.4)        67 (31.8)           3.29\*               0.07
  Pericardial effusion, *n* (%)         112 (16.6)        47 (22.3)           3.46\*               0.06
  EF (%), mean ± SD                     64.0 ± 0.7        65.0 ± 0.5          4.82^†^              0.35
  False lumen \> true lumen, *n* (%)    210 (31.2)        62 (29.4)           0.25\*               0.62
  SBP on admittance (mmHg), mean ± SD   151.9 ± 29.7      147.8 ± 29.4        0.05^†^              0.83
  DBP on admittance (mmHg), mean ± SD   87.1 ± 19.0       80.6 ± 19.2         0.12^†^              0.73

EF: Ejection fraction; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; SD: Standard deviation; 1 mmHg=0.133 kPa. \*: Chi-square test; ^†^: *t*-test.

Sex-related differences in inhospital management and complications {#sec2-7}
------------------------------------------------------------------

Overall, 6.2% (55 of 884) of patients with AAD died before vascular or endovascular surgery was performed, 34.4% (304 of 884) underwent surgical procedures, and 52.7% (466 of 884) and 12.8% (113 of 884) received endovascular treatment and medication. In surgically managed patients, hypothermic circulatory arrest, aortic cross-clamp time, and extracorporeal circulation time were equally distributed in groups. In patients who underwent endovascular surgery, the number of stent grafts implanted has no difference between men and women. There were no significant differences in medicine used \[[Table 2](#T2){ref-type="table"}\]. As shown in [Table 3](#T3){ref-type="table"}, inhospital complications including pulmonary complications, acute renal insufficiency (ARI), paraplegia, encephalopathy, myocardial ischemia, and length of stay occurred commonly in both men and women. Postoperative mortality was 6.0% (38 of 634) and 5.6% (11 of 195) between men and women, respectively \[[Table 3](#T3){ref-type="table"}\].

###### 

Inhospital treatments and surgical data of acute aortic dissection patients

  Characteristics                                                      Men (*n* = 673)    Women (*n* = 211)   Statistical values   *P*
  -------------------------------------------------------------------- ------------------ ------------------- -------------------- ------
  Surgery, *n* (%)                                                                                                                 
   Type A dissection                                                   220 (32.7)         79 (37.4)           1.62\*               0.20
   Type B dissection                                                   4 (0.6)            1 (0.5)             1.62\*               0.20
  Endovascular treatment, *n* (%)                                                                                                  
   Type A dissection                                                   1 (0.1)            2 (0.9)             3.03\*               0.14
   Type B dissection                                                   370 (55.0)         93 (44.1)           7.65\*               0.01
  Medicine, *n* (%)                                                                                                                
   Type A dissection                                                   37 (5.5)           16 (7.6)            1.24\*               0.27
   Type B dissection                                                   40 (5.9)           20 (9.5)            3.17\*               0.08
  Hypothermic circulatory arrest (min), median (interquartile range)   37.0 (28.0,47.0)   36.0 (29.0,46.5)    0.01^‡^              0.95
  Aortic cross-clamp time (min), mean ± SD                             117.2 ± 35.1       114.5 ± 26.9        2.16^†^              0.14
  Extracorporeal circulation time (min), mean ± SD                     200.3 ± 61.7       194.9 ± 45.2        0.83^†^              0.36
  Number of stent grafts implanted, median (Q~1~, Q~3~)                1 (1, 1)           1 (1, 1)            1.40^‡^              0.24
  Completely covering of the LSA, *n* (%)                              45 (6.7)           10 (4.7)            1.04\*               0.31
  Species of medical, median (Q~1~, Q~3~)                              4 (2, 5)           3 (2, 5)            0.47^‡^              0.88
  Sodium nitroprusside, *n* (%)                                        500 (74.3)         149 (70.6)          1.11\*               0.29
  Beta-blocker, *n* (%)                                                619 (92.0)         192 (91.0)          0.24\*               0.65
  Angiotensin II receptor blocker, *n* (%)                             156 (23.2)         42 (19.9)           0.99\*               0.32
  ACE inhibitor, *n* (%)                                               461 (68.5)         139 (65.9)          0.51\*               0.48
  Calcium-channel blocker, *n* (%)                                     563 (83.7)         167 (79.1)          2.27\*               0.13
  Aspirin, *n* (%)                                                     152 (22.6)         43 (20.4)           0.46\*               0.50
  Statin, *n* (%)                                                      161 (23.9)         43 (20.4)           1.14\*               0.29

LSA: left subclavian artery; SD: standard deviation; ACE: angiotensin converting enzyme. \*Chi-square test; ^†^*t*-test; ^‡^Mann-Whitney *U*-test.

###### 

Postoperative outcomes of acute aortic dissection patients

  Characteristics                Men (*n* = 634)   Women (*n* = 195)   Statistical values   *P*
  ------------------------------ ----------------- ------------------- -------------------- ------
  Pulmonary, *n* (%)             41 (6.5)          12 (6.2)            0.02\*               0.88
  ARI, *n* (%)                   78 (12.3)         16 (8.2)            2.49\*               0.11
  Paraplegia, *n* (%)            3 (0.5)           1 (0.5)             0.01\*               1.00
  Encephalopathy, *n* (%)        31 (4.9)          10 (5.1)            0.02\*               0.89
  Myocardial ischemia, *n* (%)   46 (7.3)          18 (9.2)            0.82\*               0.37
  LOS (days), mean ± SD          13.5 ± 2.3        13.6 ± 1.6          0.75^†^              0.39
  Mortality, *n* (%)             38 (6.0)          11 (5.6)            0.03\*               0.86
   Type A                        30 (4.7)          10 (5.1)            0.05\*               0.82
   Type B                        8 (1.3)           1 (0.5)             0.24\*               0.63

ARI: Acute renal insufficiency; LOS: Length of stay; SD: Standard deviation. \*Chi-square test; ^†^*t*-test.

Sex-related differences in mortality during follow-up {#sec2-8}
-----------------------------------------------------

Follow-up was completed in 653 of 829 patients (78.8%). [Figure 1](#F1){ref-type="fig"} shows the survival of women versus men stratified by type of dissection. The follow-up ranged from 2 to 168 months (median, 24 months), there were 38 deaths (6.0%) in male patients and 11 deaths (5.6%) in female patients; there was no significant difference among these groups (*χ*^2^ = 0.03, *P* = 0.91). No significant sex-related difference was found in mortality between Type A and B dissections \[[Figure 1](#F1){ref-type="fig"}\]. Adjustment for age, history of coronary disease, hypertension, smoking and drinking, Type A and use of beta-blocker, angiotensin II receptor blockers, angiotensin converting enzyme (ACE) inhibitor, calcium-channel blockers, and statins by multivariate logistic regression analysis suggested that age (OR, 1.04; 95% confidence interval \[*CI*\], 1.01--1.07; *P* \< 0.05), using of calcium-channel blockers (OR, 0.37; 95% CI, 0.18--0.74; *P* \< 0.05), at discharge were independent predictors of late mortality, ACE inhibitors (OR,1.91; 95% CI, 1.03--3.54; *P* = 0.04) was independent risk factor of late mortality \[[Table 4](#T4){ref-type="table"}\].

![Survival curves for men and women with acute aortic dissection stratified by type of dissection (type A and type B). Log-rank test *P*~1~ = 0.793 for type A dissection and log-rank *P*~2~ = 0.560 for type B dissection in the two genders.](CMJ-131-1430-g001){#F1}

###### 

Independent effects on late mortality survival

  Characteristics                                *OR*   95% *CI*     *P*
  ---------------------------------------------- ------ ------------ -------
  Gender                                         0.90   0.41--1.98   0.790
  Age                                            1.04   1.01--1.07   0.003
  Smoking                                        1.10   0.62--1.94   0.750
  Drinking                                       1.18   0.61--2.26   0.620
  Coronary disease                               0.86   0.35--2.12   0.750
  Hypertension                                   0.86   0.41--1.77   0.670
  Type A                                         1.03   0.50--2.12   0.930
  Pleural effusion                               1.39   0.74--2.62   0.310
  Pericardial effusion                           1.20   0.54--2.71   0.650
  Beta-blocker at discharge                      0.57   0.28--1.14   0.110
  Angiotensin II receptor blocker at discharge   0.69   0.22--2.14   0.520
  ACE inhibitor at discharge                     1.91   1.03--3.54   0.040
  Calcium-channel blocker at discharge           0.37   0.18--0.74   0.005
  Statin at discharge                            0.43   0.17--1.08   0.070

*OR*: Odds ratio; *CI*: Confidence interval; ACE: Angiotensin converting enzyme.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Although sex-related differences in outcomes of acute coronary syndromes are well documented,\[[@ref12]\] such information is not available for patients with aortic dissection. This study based on large-scale and long-term follow-up in the Chinese population that provides evidence on the incidence, evolution, follow-up, and multivariate predictors of aortic dissection. The principal findings of this analysis were as follows. First, during the follow-up, the use of ACE inhibitors was associated with a risk of long-term aortic events in patients with aortic dissection, which might contribute greatly to guiding clinical practice. Second, calcium-channel blockers were associated with improved survival in aortic dissection.

In 2004, Nienaber *et al*.\[[@ref13]\] provided the first systematic registry analysis of a large series of patients with AAD. The study found a higher death rate in women with Type A dissection than that in men, including a 9% point higher rate of all-cause inhospital mortality (30.1% vs. 21.0%, *P* \< 0.001). The study showed that the rates of inhospital complications were similar between men and women. Differences in phenotype, habits, customs, and diet between Chinese and Western populations might also affect treatment outcomes.

Several studies have shown that outcomes for women who underwent surgery for aortic dissection were worse than for men.\[[@ref13][@ref14][@ref15]\] The present study showed that outcomes were similar in both sexes. This difference can explain as follows. First, other studies have reported that aortic dissection occurs on average 6 or 7 years later in women compared with in men and that 50% of women with aortic dissection were ≥70 years of age. In this cohort, there was no significant difference in age between men and women. Second, men seem more likely to experience more abrupt onset of pain,\[[@ref13]\] and thus timely hospital presentation. Third, pleural and pericardial and other imaging findings suggestive of impending rupture were seen more often in women. Our results showed that complications with aortic dissection were similar between men and women.

In 2008, Takeshita *et al*.\[[@ref16]\] reported that treatment with ACE inhibitors was associated with a significantly reduced risk of dissection-related aortic events in patients who survived the acute phase. Similarly, a study of 15,326 patients with a primary diagnosis of ruptured or intact abdominal aortic aneurysm, found an association of ACE inhibitors with a reduced risk of ruptured abdominal aortic aneurysm.\[[@ref17]\] Suzuki, *et al*.\[[@ref16]\] reported that use of angiotensin-converting enzyme (ACE) inhibitor was associated with a reduced risk of long-term aortic events in patients. Our results showed that ACE inhibitor therapy was an independent risk factor for late mortality. The potential mechanism remains unknown.

The use of calcium-channel blocker therapy was a reduced independent risk factor for late mortality. Some related reports pointed out that calcium-channel blockers are associated with reduced aortic expansion and improved survival in AAD.\[[@ref18][@ref19]\] Calcium antagonists generally blocked the slow calcium channels, decreasing the influx of extracellular calcium,\[[@ref20]\] which resulted in suppression of the sinoatrial and atrioventricular nodes,\[[@ref21]\] vascular dilation with decreased blood pressure, and reduced cardiac contractility. Adequate blood pressure regulation and subsequent decreased pressure on the aortic wall through calcium-channel blockade may theoretically decrease risks of aortic enlargement. The role of calcium-channel blockers in the management of aortic dissection, in general, remains poorly addressed.

Some trials have found statin therapy to be independently associated with better long-term survival of aortic aneurysms.\[[@ref22][@ref23][@ref24]\] Possibly owing to reasons as follows: The pleiotropic effects of statins, which influence endothelial function, inflammatory response, thrombus formation, and plaque stability, could affect postoperative and long-term outcomes.\[[@ref25][@ref26]\] The other effect is thought to be related to downregulation of metalloproteinases.\[[@ref27][@ref28][@ref29]\] This may be similar in principle to studies showing a minimal change of the coronary lumen but marked decreases in the numbers of deaths and myocardial infarctions in patients receiving statin therapy for coronary atherosclerosis.\[[@ref30]\] Our multivariate logistic regression analysis demonstrated that statin therapy was not an independent risk factor for late mortality. The differences between the Eastern and Western suggest that race, habits, and customs might affect treatment strategies. Thus, data and evidence for AAD therapy must be obtained for the Chinese population.

The present study is a retrospective observational study with inherent limitations. First, due to the non-randomized design and low incidence of aortic dissection in the normal population, the study should be considered as a hypothesis-generating one. Second, we have no way to confirm by imaging techniques the exact time of AAD onset or evolution. Furthermore, large-scale randomized controlled trial studies are required.

In summary, our results show that early and late mortality are similar in AAD patients of both sexes. Treatment with ACE inhibitors, calcium-channel blockers, and statins at discharge might help to improve long-term outcomes.
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